The Week

Colgate (CL) fell 1.61% this week to $86.06, while the S&P 500 gained 1.21%, leaving the stock about 2.82 percentage points behind the benchmark. The week unfolded as a choppy pullback: shares opened Monday at $87.26, reached an intraday high of $87.55 on Tuesday, slipped below $86 on Wednesday, touched $85.29 on Thursday, and edged up to close at $86.06 on Friday. The weekly range was 2.87%.

Key Events

The week’s company news centred on dividends and product launches. On Monday, Piper Sandler maintained its buy rating on Colgate-Palmolive. On Tuesday, the company announced a fourth-quarter 2026 dividend of R$0.26 per unit. From Wednesday, Tom’s of Maine drew attention with the launch of a fluoride-free hydroxyapatite toothpaste at $11.99 on Amazon, positioned as a response to rising consumer demand for hydroxyapatite formulas. Separately, one report noted Colgate’s removal from the S&P 100, while arguing it remains a sound long-term holding. No earnings or regulatory developments surfaced this week.

Analyst Ratings

Across 21 covering institutions, 7 rate the stock buy and 6 rate it overweight, with 8 at hold and none at underweight or sell. The consensus rating is buy, and the consensus target price of $98.80 sits about 14.8% above the latest close. Target prices range from $87 to $110, suggesting limited disagreement. Within the household cleaning products industry, Colgate ranks 3rd out of 12 names.

The Week Ahead

Next week’s calendar is macro-heavy. The Dallas Fed manufacturing business activity index lands on Monday, followed on Tuesday by FHFA house prices, the Case Shiller home price index, JOLTS job openings and consumer confidence. Colgate’s fiscal Q3 2026 earnings are scheduled for 30 October before the open, outside next week’s window, so the coming days serve mainly as a macro check for the consumer sector.

In Short

Colgate pulled back this week, but the broker picture remains constructive: the consensus rating is buy, the consensus target sits about 14.8% above the spot price, and the stock ranks near the top of its industry. Against that, the latest session’s flows show small and medium orders favouring the sell side while large lots were mild net buyers, pointing to a split tape. The test ahead is whether the late-October quarterly print can support the product-innovation and dividend narrative, and how macro data shapes sentiment toward consumer staples.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.